Mitchell R. Zeller, director of the Center for Tobacco Products (CTP) at the U.S. Food and Drug Administration (FDA), will provide an update on the FDA’s comprehensive plan for tobacco and nicotine products at the Food and Drug Law Institute’s (FDLI) Tobacco and Nicotine Products Regulation and Policy Conference on Oct. 21, 2020, at 11:15 a.m. Eastern time.
This year’s conference brings together a diverse group of stakeholders, including public health advocates, researchers, manufacturers, lawyers, consumer interest groups, entrepreneurs, governmental agencies and others to discuss effective regulation across the broad spectrum of tobacco and nicotine products in the United States.
Panelists will examine the public health impact of regulating nicotine content across the broad spectrum of tobacco and nicotine products; the ways in which policies can help minimize users’ health risks; and the mitigation of potential unintended consequences.